Funds · compare two funds
Are these two funds really different?
Pick two funds to see how much of their Indian equity is the same: the companies both hold, and what each holds that the other does not.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
PGIM INDIA HEALTHCARE FUND vs Mirae Asset Healthcare Fund
Overlap adds up, for every company both funds hold, the smaller of its two shares of each fund’s disclosed Indian equity: identical portfolios overlap 100%, funds with nothing in common 0%. A figure describes how alike the portfolios are; it is not a judgement of either fund. Method →
See both funds combined in the Portfolio X-ray →
Top shared holdings
17 companies both funds hold · largest common part first
| Company | Sector | In A | In B | Common part |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | 10.80% | 10.15% | 10.15% |
| Divi's Laboratories Limited | Healthcare | 10.92% | 9.79% | 9.79% |
| Torrent Pharmaceuticals Limited | Healthcare | 8.95% | 6.80% | 6.80% |
| Krishna Institute of Medical Sciences Limited | Healthcare | 3.15% | 3.39% | 3.15% |
| Dr. Lal Path Labs Ltd. | Healthcare | 4.56% | 2.90% | 2.90% |
| Aster DM Quality Care Limited | Healthcare | 2.70% | 3.33% | 2.70% |
| Sai Life Sciences Limited | Healthcare | 2.68% | 3.23% | 2.68% |
| Max Healthcare Institute Limited | Healthcare | 4.97% | 2.35% | 2.35% |
| Mankind Pharma Limited | Healthcare | 4.26% | 2.24% | 2.24% |
| Cipla Limited | Healthcare | 2.15% | 2.63% | 2.15% |
| Lupin Limited | Healthcare | 2.04% | 2.27% | 2.04% |
| IPCA Laboratories Limited | Healthcare | 2.02% | 3.39% | 2.02% |
| Gland Pharma Limited | Healthcare | 1.58% | 2.69% | 1.58% |
| Fortis Healthcare Limited | Healthcare | 1.53% | 2.94% | 1.53% |
| Symbiotec Pharmalab Limited | Not classified | 1.16% | 1.60% | 1.16% |
| Anthem Biosciences Limited | Healthcare | 1.91% | 0.93% | 0.93% |
| Molbio Diagnostics Limited | Not classified | 0.84% | 1.77% | 0.84% |
Only in A
14 companies · largest first
- Ajanta Pharma Limited5.23%
- Manipal Health Enterprises Limited3.87%
- Navin Fluorine International Limited3.42%
- Abbott India Limited3.29%
- Rubicon Research Limited3.15%
- Neuland Laboratories Limited3.06%
- ICICI Lombard General Insurance Company Limited2.21%
- Zydus Lifesciences Limited2.15%
- Dr Agarwals Eye Hospital Limited1.96%
- Global Health Limited1.61%
- Jupiter Life Line Hospitals Limited1.54%
- Lenskart Solutions Limited1.04%
- Orchid Pharma Limited0.83%
- SAGILITY LIMITED0.42%
Only in B
12 companies · largest first
- Apollo Hospitals Enterprise Limited5.62%
- Laurus Labs Limited5.51%
- Dr. Reddy's Laboratories Limited4.84%
- Glenmark Pharmaceuticals Limited4.78%
- Aurobindo Pharma Limited3.78%
- Alkem Laboratories Limited3.76%
- Onesource Specialty Pharma Limited3.01%
- Eris Lifesciences Limited2.39%
- Biocon Limited2.01%
- Neogen Chemicals Limited1.50%
- Deepak Nitrite Limited0.40%
- Narayana Hrudayalaya Ltd.0.00%
Sector mix side by side
Share of each fund’s disclosed equity
| Sector | A | B | Difference |
|---|---|---|---|
| Healthcare | 82.7% | 94.7% | -12.02 pp |
| Chemicals | 3.4% | 1.9% | +1.51 pp |
| Financial Services | 2.2% | 0.0% | +2.21 pp |
| Consumer Services | 1.0% | 0.0% | +1.04 pp |
| Information Technology | 0.4% | 0.0% | +0.42 pp |
| Not classified | 10.2% | 3.4% | +6.83 pp |
Built from each fund’s latest monthly disclosure of Indian listed shares, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not part of the comparison. Not a recommendation. Method →